February 12, 2009

Satyam: The Great Deception

 

Dear All,

The extent and audacity of what transpired at Satyam Computer Services in January, culminating in the historic confession letter of former chairman B Ramalinga Raju, admitting a fraud of US$1.6 billion, has caused investors and regulators everywhere to re-examine corporate governance standards.

Need has now arisen to introspect into how this happened and whether the current laws are adequate to counter such frauds? The Indian corporate governance regime is fairly detailed and similar to most developed countries. It is for this reason that stakeholders need to be more careful post-Satyam, because if a Satyam can happen in India, it can happen elsewhere as well. A post mortem is clearly essential. Where did the systems fail? Whose fault was this? Will the shareholders and investors receive any pecuniary compensation for the losses that they suffered? A detailed insight into the corporate governance regime is much warranted. Satyam does offer salutary lessons to companies across the globe.

We, at Nishith Desai Associates, in step with our tradition of being a research oriented law firm have attempted to answer these questions and in that stride, analyzed certain key aspects of the scandal.

Please click here to view our article “Satyam: The Great Deception” written by Ruchir Sinha and Nishchal Joshipura of Nishith Desai Associates in collaboration with Asialaw (www.asialaw.com) which not just provides a detailed step by step insight into what and how did Satyam happen, but also what should be the next steps for the regulators and those vested with corporate responsibility to ensure that a Satyam is never repeated.

Asialaw is one of the most prestigious legal journals in the Asian legal market, and the article “Satyam: The Great Deception” features as the cover story for Asialaw’s February edition.

As you would be aware, we have been providing regular information on latest legal developments. M&A Lab is our latest initiative to provide you in depth and knowledge based analysis of latest M&A deals. We will be happy to have your views / comments on our initiative. Please read the disclaimer carefully.

This article can be best viewed in Adobe Acrobat version 7.

 Team M&A
You can direct your queries or comments to Team M&A
 

Welcome to connect with us at interesting conferences, seminars and events (more...

 
  VIDEO
Vyapak Desai on FII, FDI norms
Kartik Ganapathy on Ranbaxy Daiichi deal
Nishith Desai on Vodafone Controversy
Siddharth Shah on P Notes
 
M&A Lab
HCL – Axon Deal Dissected, December 19, 2008
Zandu - Emami Hostile Turned Friendly M&A Deal Dissected, December 3, 2008
Ranbaxy - Daiichi Deal Dissected, November 14, 2008
 
  ARTICLES, HOTLINES & RESEARCH REPORTS
FCCB buybacks: Is the move enough?, The Economic Times, Ruchir Sinha & Nishchal Joshipura, January 6, 2009
Dual listed M&As: Live-in status in corporate world, The Economic Times, R Vaidhyanadhan Iyer & Vedant Shukla, December 17, 2008
SEBI goes the distance in easing takeover regulations, The Economic Times, Ruchir Sinha & Nishchal Joshipura, November 11, 2008
Is it time to bid adieu to ‘poison pills’? The Economic Times, R Vaidhyanadhan Iyer & Nishchal Joshipura, May 27, 2008
Amendments To Takeover Code – Oversight Or Intended?, November 7, 2008 
Mergers & Acquisitions in India  
Venture Capital at Crossroads
 
  SUBSCRIPTION

We update our clients by sending various hotlines. You can subscribe to one / more hotlines also. You can email us for registering yourself for any of the hotlines given below.

Corpsec Hotline
Tax Hotline
HR Hotline
iCe Hotline
Annual Budget
FII Hotline
Pharma Update
Infra Update
IP Update
Dispute Resolution Hotline


Unsubscribe
Feedback





Disclaimer: The contents of this hotline should not be construed as legal opinion. View detailed disclaimer.

This M&A Lab provides general information existing at the time of preparation. The M&A Lab is intended as a news update and Nishith Desai Associates neither assumes nor accepts any responsibility for any  loss arising to any person acting or refraining from acting as a result of any material contained in this M&A Lab. It is recommended that professional advice be taken based on the specific facts and circumstances. This M&A Lab does not substitute the need to refer to the original pronouncements.

This is not a Spam mail. You have received this mail because you have either requested for it or someone must have suggested your name. Since India has no anti-spamming law, we refer to the US directive, which states that a mail cannot be considered Spam if it contains the sender's contact information, which this mail does. In case this mail doesn't concern you, please unsubscribe from mailing list.